Skip to main content
Clinical Trials/IRCT20170716035105N3
IRCT20170716035105N3CompletedPhase 2

Investigating the Analgesia and Sedation Effects of Ketamine Infusion and Intravenous Morphine in Reducing the Pain of Short and Long Bone Fractures of Upper or Lower Extremities

Ahvaz University of Medical Sciences0 sites120 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • The criteria for entering the study are all patients with aged 65-18 years old trauma who go directly to the emergency department.

Exclusion Criteria

  • In this study, all people with any history of ketamine, morphine hypersensitivity, evidence of abnormal brain such as hydrocephalus, microcephaly, lumps, evidence of increased intracranial pressure, seizure, apnea history, respiratory problems, airway problems, heart problems And vascular, history of severe brain trauma, no premeditated sedimentation and the need for a higher dose of the drug, and also if the patient is dissatisfied with the research.

Investigators

Similar Trials

The effect of analgesia and sedation of... | Clinical Trial